Experienced in Chronic B-Cell Leukemia (CBCL)

Mehmet S. Dal

Ankara, TR 
Experienced in Chronic B-Cell Leukemia (CBCL)
Ankara, TR 
OverviewLocationsClinical Research

Overview

Mehmet Dal practices in Ankara, Turkey. Mr. Dal is rated as an Experienced expert by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Febrile Neutropenia, Hodgkin Lymphoma, B-Cell Lymphoma, Bone Marrow Transplant, and Splenectomy.

His clinical research consists of co-authoring 124 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Chronic B-Cell Leukemia (CBCL).

Gender
Male

Locations

Ankara, Turkey
Other Locations
Diyarbakir, Turkey
Afyonkarahisar, Turkey
Dicle, Turkey
Yenisehir, 21280, Turkey

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase III, Multicenter, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Pomalidomide and Dexamethasone (B-Pd) Versus Pomalidomide Plus Bortezomib and Dexamethasone (PVd) in Participants With Relapsed/Refractory Multiple Myeloma (DREAMM 8)
A Phase III, Multicenter, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Pomalidomide and Dexamethasone (B-Pd) Versus Pomalidomide Plus Bortezomib and Dexamethasone (PVd) in Participants With Relapsed/Refractory Multiple Myeloma (DREAMM 8)
Enrollment Status: Active_not_recruiting
Publish Date: March 18, 2025
Intervention Type: Drug
Study Drugs: Belantamab Mafodotin, Pomalidomide, Dexamethasone, Bortezomib
Study Phase: Phase 3

123 Total Publications

Is there a relationship between stem cell yield obtained from healthy donors and healthy donors' blood type?
Is there a relationship between stem cell yield obtained from healthy donors and healthy donors' blood type?
Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
Published: July 08, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Dal's expertise for a condition
ConditionClose
      View All 7 Advanced Conditions
      View All 51 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile